161 related articles for article (PubMed ID: 2105731)
21. Ionic regulation of human basophil releasability. III. Effects of Na+ and Ca2+ on histamine release induced by different stimuli.
Tedeschi A; Palella M; Arquati M; Milazzo N; Miadonna A
Pharmacol Res; 1994; 30(3):229-41. PubMed ID: 7532302
[TBL] [Abstract][Full Text] [Related]
22. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
23. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils.
Borrelli I; Loffredo S; Staiano RI; Frattini A; Marone G; Triggiani M
Int J Immunopathol Pharmacol; 2010; 23(3):737-44. PubMed ID: 20943043
[TBL] [Abstract][Full Text] [Related]
24. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
25. Characterization of human synovial mast cells.
Kopicky-Burd JA; Kagey-Sobotka A; Peters SP; Dvorak AM; Lennox DW; Lichtenstein LM; Wigley FM
J Rheumatol; 1988 Sep; 15(9):1326-33. PubMed ID: 2462048
[TBL] [Abstract][Full Text] [Related]
26. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli.
Warner JA; Peters SP; Lichtenstein LM; Hubbard W; Yancey KB; Stevenson HC; Miller PJ; MacGlashan DW
J Leukoc Biol; 1989 Jun; 45(6):558-71. PubMed ID: 2470847
[TBL] [Abstract][Full Text] [Related]
27. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
[TBL] [Abstract][Full Text] [Related]
28. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol.
Marone G; Ambrosio G; Bonaduce D; Genovese A; Triggiani M; Condorelli M
Int Arch Allergy Appl Immunol; 1984; 74(4):356-61. PubMed ID: 6203844
[TBL] [Abstract][Full Text] [Related]
30. Effect of R59022, an inhibitor of diacylglycerol kinase, on IgE-mediated histamine release from human lung mast cells and basophils.
O'Keefe KL; Warner JA
Agents Actions; 1994 Nov; 43(1-2):1-6. PubMed ID: 7537937
[TBL] [Abstract][Full Text] [Related]
31. General anaesthetics induce only histamine release selectively from human mast cells.
Stellato C; Casolaro V; Ciccarelli A; Mastronardi P; Mazzarella B; Marone G
Br J Anaesth; 1991 Dec; 67(6):751-8. PubMed ID: 1722691
[TBL] [Abstract][Full Text] [Related]
32. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
33. Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release.
Stellato C; de Crescenzo G; Patella V; Mastronardi P; Mazzarella B; Marone G
J Allergy Clin Immunol; 1996 Mar; 97(3):838-50. PubMed ID: 8613641
[TBL] [Abstract][Full Text] [Related]
34. Comparative studies of mediator release from guinea pig lung mast cells and basophils.
Undem BJ; Brendel JB; Hirth T; Buckner CK; Graziano FM
Am Rev Respir Dis; 1986 May; 133(5):763-8. PubMed ID: 2422992
[TBL] [Abstract][Full Text] [Related]
35. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
[TBL] [Abstract][Full Text] [Related]
36. The mechanism of mediator release from human basophils induced by platelet-activating factor.
Columbo M; Casolaro V; Warner JA; MacGlashan DW; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1990 Dec; 145(11):3855-61. PubMed ID: 1700998
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
[TBL] [Abstract][Full Text] [Related]
38. Human basophil releasability. III. Genetic control of human basophil releasability.
Marone G; Poto S; Celestino D; Bonini S
J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
[TBL] [Abstract][Full Text] [Related]
39. Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics.
Casolaro V; Galeone D; Giacummo A; Sanduzzi A; Melillo G; Marone G
Am Rev Respir Dis; 1989 Jun; 139(6):1375-82. PubMed ID: 2471428
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human basophil leukotriene release by antiinflammatory steroids.
Schleimer RP; Davidson DA; Peters SP; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):241-3. PubMed ID: 3874167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
